Washington, DC – February 1, 2017 – ASM Journals Board Chair, Tom Shenk has issued a call for the next Editor in Chief of Molecular and Cellular Biology® (MCB). Coinciding with the appointment of the new Editor in Chief in July 2017, MCB will expand its scope to highlight cutting-edge research on the role of infectious agents in chronic diseases.
Over the last decade, compelling new evidence has emerged connecting microbes and such chronic diseases as cancer, immune-related syndromes, cardiovascular disease, gastrointestinal disorders, and neurodegenerative diseases, as well chronic conditions like obesity and those associated with aging. Looking forward to the next decade of research in MCB, the MCB editorial staff has identified an additional focus for the journal: exploring the role of microbes, viruses, and prions in chronic disease.
MCB will place particular emphasis on the mechanisms needed to establish causality for these associations. MCB will continue to encourage submissions of work on the fundamental molecular biology of eukaryotic cells, and also will welcome:
• Systems-level studies exploring relationships between the microbiome/virome and chronic diseases or conditions
• Mechanistic studies at the molecular, cellular, or whole animal level that illuminate fundamental processes underlying the role of bacteria, viruses, yeasts, and prions in chronic diseases or conditions
Since its launch in 1981, MCB has been devoted to the advancement of fundamental knowledge concerning the molecular biology of eukaryotic cells, both microbial and higher organisms. MCB has published many important, highly cited papers on cellular morphology and function, genome organization, regulation of genetic expression, morphogenesis, and somatic cell genetics.
The current MCB Editor in Chief, Roger Davis, will retire on June 30th, 2017, after 10 years’ outstanding service as Editor in Chief, and 10 years as an editor of MCB. Dr. Davis received his BA (1979) and his PhD (1983) from the Department of Biochemistry at Cambridge University (U.K.). Dr. Davis has been a faculty member at the University of Massachusetts Medical School since 1985. He has served on numerous scientific advisory boards, and he is an Investigator of the Howard Hughes Medical Institute, a Fellow of the Royal Society, and the H. Arthur Smith Chair in Cancer Research at University of Massachusetts Medical School.
Nominations are being accepted now for the next MCB Editor in Chief, whose initial five-year term will begin July 1, 2017. The new Editor in Chief will shape the vision, editorial structure, and peer review standards for the journal and will receive strong support from the Society leadership and staff.
MCB will continue to welcome submissions from authors around the world and will provide rapid decisions on publication, while carrying on ASM’s tradition for rigorous peer review.
Please email your nomination by March 1, 2017, to Tom Shenk, ASM Journals Board Chair, at ASMjournalsboardchair@asmusa.org. Nominations should include a brief statement of the nominee’s qualifications and a biosketch or CV; self-nominations are encouraged.
The American Society for Microbiology is the largest single life science society, composed of over 48,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.